tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DNTH Stock Latest News

Promising Outlook and Strategic Positioning Make Dianthus Therapeutics a Buy
RatingsPromising Outlook and Strategic Positioning Make Dianthus Therapeutics a Buy
6d ago
DNTH
Dianthus price target raised to $42 from $34 at Wedbush
PremiumThe Fly
Dianthus price target raised to $42 from $34 at Wedbush
11d ago
DNTH
Dianthus Therapeutics: Promising Developments and Market Potential Drive Buy Rating
PremiumRatings
Dianthus Therapeutics: Promising Developments and Market Potential Drive Buy Rating
19d ago
DNTH
Promising Clinical Developments and Financial Stability Drive Buy Recommendation for Dianthus Therapeutics
PremiumRatings
Promising Clinical Developments and Financial Stability Drive Buy Recommendation for Dianthus Therapeutics
21d ago
DNTH
Dianthus Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Dianthus Therapeutics Reports Q2 2025 Financial Results
25d ago
DNTH
Dianthus Therapeutics: Promising Prospects with DNTH103 and Strong Financial Position Support Buy Rating
PremiumRatingsDianthus Therapeutics: Promising Prospects with DNTH103 and Strong Financial Position Support Buy Rating
25d ago
DNTH
Promising Outlook for Dianthus Therapeutics: Buy Rating on Claseprubart’s Potential in gMG
Premium
Ratings
Promising Outlook for Dianthus Therapeutics: Buy Rating on Claseprubart’s Potential in gMG
25d ago
DNTH
Dianthus reports Q2 EPS (88c), consensus (87c)
Premium
The Fly
Dianthus reports Q2 EPS (88c), consensus (87c)
25d ago
DNTH
3 Best Stocks to Buy Now, 7/29/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/29/2025, According to Top Analysts
1M ago
DNTH
HRMY
Dianthus Therapeutics’ CAPTIVATE Study: A Potential Game-Changer for CIDP Treatment
PremiumCompany Announcements
Dianthus Therapeutics’ CAPTIVATE Study: A Potential Game-Changer for CIDP Treatment
1M ago
DNTH
Dianthus price target raised to $92 from $84 at Guggenheim
PremiumThe Fly
Dianthus price target raised to $92 from $84 at Guggenheim
1M ago
DNTH
Dianthus Therapeutics’ DNTH103: A Promising Complement Inhibitor with Upcoming Catalysts
PremiumRatings
Dianthus Therapeutics’ DNTH103: A Promising Complement Inhibitor with Upcoming Catalysts
2M ago
DNTH
Dianthus initiated with an Outperform at William Blair
PremiumThe FlyDianthus initiated with an Outperform at William Blair
2M ago
DNTH
Dianthus Therapeutics: Promising Prospects in Autoimmune Complement Inhibitor Market with DNTH103 Advancements
Premium
Ratings
Dianthus Therapeutics: Promising Prospects in Autoimmune Complement Inhibitor Market with DNTH103 Advancements
2M ago
DNTH
Optimistic Buy Rating for Dianthus Therapeutics Amidst Promising C1s Inhibition Developments
Premium
Ratings
Optimistic Buy Rating for Dianthus Therapeutics Amidst Promising C1s Inhibition Developments
2M ago
DNTH
Buy Rating for Dianthus Therapeutics: Promising Growth Potential of DNTH103 in Neuromuscular Disease Treatment
PremiumRatings
Buy Rating for Dianthus Therapeutics: Promising Growth Potential of DNTH103 in Neuromuscular Disease Treatment
2M ago
DNTH
Dianthus Therapeutics Announces Board Changes and Elections
PremiumCompany Announcements
Dianthus Therapeutics Announces Board Changes and Elections
3M ago
8K
DNTH
Buy Rating Affirmed for Dianthus Therapeutics: Promising Clinical Potential of DNTH103 in CIDP Treatment
PremiumRatings
Buy Rating Affirmed for Dianthus Therapeutics: Promising Clinical Potential of DNTH103 in CIDP Treatment
3M ago
DNTH
Dianthus Therapeutics: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
PremiumRatings
Dianthus Therapeutics: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
4M ago
DNTH
Dianthus price target lowered to $50 from $58 at Baird
PremiumThe FlyDianthus price target lowered to $50 from $58 at Baird
4M ago
DNTH
Promising Developments and Strong Financials Support Buy Rating for Dianthus Therapeutics
Premium
Ratings
Promising Developments and Strong Financials Support Buy Rating for Dianthus Therapeutics
4M ago
DNTH
Dianthus Therapeutics Reports Increased R&D Expenses
Premium
Company Announcements
Dianthus Therapeutics Reports Increased R&D Expenses
4M ago
DNTH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >